144 related articles for article (PubMed ID: 11436942)
1. Effects of 2% ibopamine on pupil, refraction, anterior segment anatomy and intraocular pressure.
Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
J Ocul Pharmacol Ther; 2001 Jun; 17(3):215-23. PubMed ID: 11436942
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
[TBL] [Abstract][Full Text] [Related]
3. Effect of ibopamine on aqueous humor production in normotensive humans.
McLaren JW; Herman DC; Brubaker RF; Nau CB; Wayman LL; Ciarniello MG; Rosignoli MT; Dionisio P
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4853-8. PubMed ID: 14578408
[TBL] [Abstract][Full Text] [Related]
4. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.
Giuffrè I; Taverniti L; Di Staso S
Eur J Ophthalmol; 2004; 14(6):508-13. PubMed ID: 15638100
[TBL] [Abstract][Full Text] [Related]
5. Ibopamine test in healthy and glaucomatous eyes: tonometric and pupillographic study.
Brogliatti B; Boles Carenini A; Bogetto C; Vadalà G; Grignolo FM; Boles Carenini B
Acta Ophthalmol Scand Suppl; 2000; (232):13-4. PubMed ID: 11235513
[No Abstract] [Full Text] [Related]
6. Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
Landers J; Ullrich K; Craig JE
Clin Exp Ophthalmol; 2015 Dec; 43(9):808-14. PubMed ID: 26140527
[TBL] [Abstract][Full Text] [Related]
7. Correlation between ocular hypertension induced by ibopamine and perimetric defect in primary open-angle glaucoma.
De Gregorio F; Pecori-Giraldi J; De Stefano C; Virno M
Eur J Ophthalmol; 1997; 7(2):152-5. PubMed ID: 9243219
[TBL] [Abstract][Full Text] [Related]
8. The comparison of topical ibopamine 2% with tonography to identify the outflow resistance in eyes with ocular hypertension.
Hepsen IF; Yilmaz H; Keskin UC
Ophthalmic Res; 2005; 37(1):17-22. PubMed ID: 15627837
[TBL] [Abstract][Full Text] [Related]
9. Ibopamine challenge test can be used to differentiate glaucoma suspects from glaucoma patients.
Ullrich K; Craig JE; Landers J
Clin Exp Ophthalmol; 2014; 42(4):342-6. PubMed ID: 24034130
[TBL] [Abstract][Full Text] [Related]
10. Effects of adrenergics, adrenolytics, cholinergics and carbonic anhydrase inhibitors on ibopamine-induced ocular hypertension in POAG.
Virno M; De Gregorio F; D'Ubaldo E; Sallucci S; De Stefano C; Sedran L
Acta Ophthalmol Scand Suppl; 1997; (224):25-6. PubMed ID: 9589717
[No Abstract] [Full Text] [Related]
11. Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination.
Magacho L; Lima FE; Costa ML; Fayad FA; Guimarães NL; Avila MP
Curr Eye Res; 2004 Mar; 28(3):189-93. PubMed ID: 14977521
[TBL] [Abstract][Full Text] [Related]
12. Increase in aqueous humor production following D1 receptors activation by means of ibopamine.
Virno M; Taverniti L; De Gregorio F; Sedran L; Longo F
Int Ophthalmol; 1996-1997; 20(1-3):141-6. PubMed ID: 9112178
[TBL] [Abstract][Full Text] [Related]
13. Ibopamine in glaucoma diagnostics: a new pharmacological provocative test.
De Gregorio F; Pecori Giraldi J; Pannarale L; Saccucci S; Virno M
Int Ophthalmol; 1996-1997; 20(1-3):151-5. PubMed ID: 9112180
[TBL] [Abstract][Full Text] [Related]
14. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
[TBL] [Abstract][Full Text] [Related]
15. Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma.
Virno M; Sampaolesi R; Pecori Giraldi J; De Gregorio F; Taloni M; Brusini P; Di Staso S; Stecchi G
J Glaucoma; 2013 Jan; 22(1):5-9. PubMed ID: 21946546
[TBL] [Abstract][Full Text] [Related]
16. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz J
Eur J Ophthalmol; 2003 May; 13(4):370-6. PubMed ID: 12872794
[TBL] [Abstract][Full Text] [Related]
17. Reversal of mydriasis by dapiprazole.
Allinson RW; Gerber DS; Bieber S; Hodes BL
Ann Ophthalmol; 1990 Apr; 22(4):131-3, 138. PubMed ID: 1972008
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the 1% and 2% ibopamine provocative test in primary open-angle glaucoma patients: sensitivity, specificity and tolerability.
Magacho L; Costa ML; Dessimoni A; de Avila MP
Arq Bras Oftalmol; 2006; 69(5):695-9. PubMed ID: 17187138
[TBL] [Abstract][Full Text] [Related]
19. Early Glaucoma Screening Using the Ibopamine Provocative Test.
Domínguez-Dueñas F; Plaza-Espinosa L; Mundo-Fernández EE; Jiménez-Reynoso CA; Barojas-Weber E; Barrientos-Gutiérrez T
J Glaucoma; 2016 May; 25(5):e441-5. PubMed ID: 26709501
[TBL] [Abstract][Full Text] [Related]
20. [Effects of combined instillation of dapiprazole and epinephrine on human anterior chamber depth, intraocular pressure and pupil diameter].
Sugiyama T; Matsuda K; Tokuoka S; Sato B; Azuma I
Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):449-52. PubMed ID: 2572162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
